SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...
Using cells from kidney biopsies, Johns Hopkins Medicine, researchers report progress in the search for more accurate and easier-to-obtain markers to help predict, manage and assess treatment of acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback